Oral Amiodarone Dosing for Atrial Fibrillation with Rapid Ventricular Response
For AF with RVR, oral amiodarone should be initiated at 600-800 mg per day in divided doses until a total loading dose of 10 grams is achieved, followed by a maintenance dose of 200 mg daily. 1
Loading Phase Dosing
The standard oral loading regimen consists of:
- 600-800 mg per day in divided doses (typically 200-400 mg three times daily)
- Continue until cumulative dose of 10 grams is reached
- This typically takes 1-2 weeks depending on daily dose
- Higher initial dosages (800-1,600 mg/day) may be used for unstable inpatients 1
Alternative rapid loading approaches have been studied:
- Single high-dose loading: 30 mg/kg as a single oral dose (approximately 2,000-2,500 mg for average adult) 2, 3
- Accelerated loading: 1.2-1.8 g per day in divided doses until 10 g total for inpatient settings 2
Maintenance Dosing
After achieving the 10-gram loading dose:
- 200 mg daily is the standard maintenance dose 1
- Some patients may require 200-400 mg daily depending on response 1
Clinical Context and Considerations
Amiodarone is particularly beneficial for AF with RVR in specific populations 1:
- Patients with heart failure or reduced ejection fraction (where beta-blockers and calcium channel blockers may be contraindicated)
- Patients with impaired renal function
- Patients with structural heart disease where Class IC agents are contraindicated
Important timing expectations: Oral amiodarone has a delayed onset of action. Antiarrhythmic effects typically begin 4-8 hours after loading and peak at 6-8 hours, with most conversions occurring after 6-8 hours of therapy 2, 4. This is significantly slower than IV administration, which acts within 30 minutes 1.
Rate Control vs. Rhythm Control Strategy
The 2006 ACC/AHA/ESC guidelines classify oral amiodarone use differently based on intent 5:
For rate control in AF with RVR: Oral amiodarone is a Class IIb recommendation (may be considered) when beta-blockers, calcium channel blockers, or digoxin fail to adequately control ventricular rate both at rest and during exercise 5.
For rhythm control/cardioversion: The dosing regimen above (600-800 mg/day loading) is appropriate for attempting pharmacological cardioversion 1, 2.
Critical Safety Warnings
Monitoring requirements 1:
- Baseline ECG to assess QT interval, PR interval, and QRS duration
- Monitor for bradycardia and AV block
- Assess for GI upset and constipation (common early side effects)
- Long-term monitoring for pulmonary, thyroid, hepatic, and ocular toxicity
Contraindications and cautions:
- Avoid in patients with severe sinus node dysfunction or second/third-degree AV block without pacemaker 6
- Use lowest effective dose due to dose-dependent toxicity 1
- Pulmonary toxicity is the most serious adverse effect, though less common at doses ≤300 mg/day 1
- Avoid in patients with prolonged QTc >500 ms 7
Outpatient vs. Inpatient Initiation
Outpatient initiation is generally safe for oral amiodarone, even in patients with persistent AF 6. However, inpatient loading may be more appropriate when:
- Earlier restoration of sinus rhythm is needed
- Patient has heart failure requiring closer monitoring
- Concern exists for proarrhythmic effects or conduction abnormalities 6
The 2024 ACC/AHA guidelines continue to support amiodarone as a reasonable option for pharmacological cardioversion in patients with structural heart disease or heart failure with reduced ejection fraction, where it remains one of the safest antiarrhythmic options 8, 7.